GOLDEN, CO--(Marketwire - Dec 18, 2012) - iSatori, Inc. (
"Three newly published research studies revealed that while losing weight and reducing body fat, especially around the waist, can be very challenging, the process can benefit from daily supplementation of CLA combined with a new weight-loss/energy blend we discovered called YGD™," stated Stephen Adele, Founder and Chief Executive Officer of iSatori, Inc. (www.isatori.com). "In all three studies, subjects were shown to lose significantly more body fat than participants who were given a placebo. In one study, none of the participants changed their eating or exercise habits during the trial period, yet those taking the new supplement still lost abdominal fat. Bolstered by these research studies, we anticipate and are gearing up for strong consumer demand for our new Belly-Off product."
Consumers should be aware that Belly-Off may be in short supply (due to the limited availability of some of the ingredients) and has already generated enthusiasm among retailers. Although it should be available on store shelves in January, just to be safe, iSatori is asking consumers to call stores first before visiting them because they expect initial supplies of Belly-Off to sell out quickly. Alternatively, consumers are being directed to the BioGenetic Laboratories website at www.BioGeneticLabs.com to purchase Belly-Off or to locate the nearest retailer.
Additional consumer weight-loss support and product information on Belly-Off can be found on the Internet at https://www.facebook.com/BiogeneticLabs.
Retailers interested in carrying Belly-Off should contact Europa Sports, America's largest sports and health supplement distributor, at 1-800-447-4795 or visit http://www.EuropaSports.com.
About iSatori, Inc.
iSatori is a consumer products firm that develops and sells nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. The Company is headquartered in Golden, Colorado, and its common stock trades on the OTCQB under the symbol "IFIT." More information about the Company is available at http://www.isatori.com.
Statements made in this news release relating to the Company's future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management's assumptions and the Company's future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company's products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. All forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update any such statement.